Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-20 · accession 0000905148-26-001015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-20 | RIGL | MOOS WALTER H | Dir | M - OptEx | $24.00 | +4,000 | 16.7K | +31% | +$96.0K |
| D | 2026-02-24 | 2026-02-20 | RIGL | MOOS WALTER H | Dir | S - Sale+OE | $36.36 | -4,000 | 12.7K | -24% | -$145.4K |
| D | 2026-02-24 | 2026-02-20 | RIGL | MOOS WALTER H | Dir | M - OptEx | $0.00 | -4,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | M | A | 4,000 | $24.00 | 16,722 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. |
| 2 | Common | Common Stock | 2026-02-20 | S | D | 4,000 | $36.36 | 12,722 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-20 | M | D | 4,000 | $0.00 | 0 | D | $24.00 · — to 2026-05-11 | 4,000 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F2) The shares vested monthly over twelve (12) months from the grant date of May 11, 2016. |